Myoglobin free serum

Cat.# 8MFS

Currently unavailable

Sign up or login to see prices and to request offers

-- / 50 ml
* All prices excluding VAT
Request an offer Sample Request

Questions? Schedule online meeting

Cardiac markers
  • Cat.#


  • Source:

    Pooled normal human serum.

    Blood samples from donors were tested and found to be negative for HBsAg, HIV-1 and HIV-2 antibodies, and HCV.

  • Application:

    Myoglobin free serum can be used for preparation of human myoglobin standards and calibrators.

  • Analysis:

    According to ELISA testing myoglobin free serum does not contain more than 1 ng/ml of human myoglobin.

  • Purification:

    Immunoaffinity chromatography of pooled normal human serum.

    Gel for affinity column was prepared by coupling anti-myoglobin monoclonal antibodies (several monoclonal antibodies specific to the N-terminal, C-terminal and central parts of myoglobin molecule) with BrCN-activated Sepharose CL 4B.

  • Presentation:

    Frozen liquid

  • Storage:

    -20 °C (-15 … -30 °C allowed)

  • Material safety note:

    This product is sold for research use only. Standard Laboratory Practices should be followed when handling this material.

  • References:

    See other cardiac markers and blood coagulation products.
    See all Myoglobin References.
    Search other references from PubMed.

  • Related products:

    Cat# 4M23: Myoglobin, Human, antibody .
    Cat# 8M50: Myoglobin.


Bulk Price Quotation

Myoglobin free serum

(Catalogue number and MAb: 8MFS-)



Sample Request

Myoglobin free serum

(Catalogue number and MAb: 8MFS-)

Evaluation samples available. You can save up to 50%*


*The usual shipping and handling costs will still apply. The sample opportunity is a one-time evaluation possibility and you can get more details by contacting HyTest customer service.

Schedule Online Meeting

Please fill in the form below and we will contact you by email and schedule a meeting.


Sign up to our newsletter

And be informed about new products and scientific findings

Thank you for your subscription!